ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1542

Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis

Ariana González-Meléndez1, Ruth Fred-Jimenez2, Mariangelí Arroyo-Ávila2, Leyda Díaz-Correa2, Naydi Pérez-Ríos3, Noelia Rodríguez-Pérez2, Grissel Ríos2 and Luis M. Vilá2, 1School of Medicine, Ponce Health Sciences University, Ponce, PR, 2Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 3Puerto Rico Clinical and Translational Research Consortium, University of Puerto Rico Medical Sciences Campus, San Juan, PR

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease and rheumatoid arthritis (RA), Hispanic patients

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Arterial vascular events have a great impact in the morbidity and mortality of rheumatoid arthritis (RA). Traditional and nontraditional risk factors for arterial vascular events vary widely among different ethnic groups. Few studies have been conducted in Hispanics from the United States. Thus, we determined the factors associated with the occurrence of arterial vascular events in a cohort of Hispanics from Puerto Rico with RA. 

Methods: RA patients (per American College of Rheumatology classification criteria) of Puerto Rican ethnicity (self and four grandparents) were studied to determine the demographic features, health-related behaviors, clinical manifestations, disease activity (per disease activity score 28 [DAS28]), comorbid conditions, functional status (per Health Assessment Questionnaire [HAQ]), and pharmacologic profile associated with arterial vascular events. An arterial vascular event was defined as the occurrence of myocardial infarction, angina pectoris, vascular procedure for coronary artery disease, stroke, or peripheral artery disease. Patient characteristics were analyzed by bivariable (chi-square and Student’s t tests) and multivariable (logistic regression) analyses.  

Results: In total, 405 RA patients were studied. The mean (standard deviation [SD]) age was 56.1 (13.9) years and the mean (SD) disease duration was 15.0 (50.7) years; 87.2% were woman. Forty-three patients (10.6%) had at least one incident arterial vascular event. In the bivariable analyses, patients with arterial vascular events were more likely to be male (23.3% vs. 11.6%, p= 0.031) and older (63.0 [11.1] vs. 55.2 [14.0] years, p<0.001) and to have more extra-articular manifestations (69.8% vs. 48.9%, p=0.010), disease activity (DAS28 score, 4.21 [1.81] vs. 3.61 [1.45], p=0.044 ), functional disability (HAQ score, 1.40 [0.89] vs. 1.09 [0.78], p=0.017 ), arterial hypertension (83.7% vs. 51.7%, p<0.001),  diabetes mellitus (25.6% vs. 13.8%, p=0.041), dyslipidemia (81.0% vs. 45.3%, p<0.001) and peripheral venous disease (11.6% vs. 3.9%, p=0.040) than those without arterial vascular events. No differences were found for disease duration, smoking, exercise, body mass index, joint deformities, erosive disease, and exposure to nonsteroidal anti-inflammatory drugs, corticosteroids, disease modifying anti-rheumatic drugs and biologic agents. In the multivariable analysis adjusted for gender and age, extra-articular manifestations (OR=2.08, 95% CI 1.03-4.20), functional status (OR=2.52, 95% CI 1.24-5.11), arterial hypertension (OR= 3.43, 95% CI 1.40-8.41), dyslipidemia (OR= 4.48, 95% CI 2.00-10.04) and peripheral venous disease (OR=2.93, 95% CI .96-8.97) retained significance.  

Conclusion: This is the first study examining the prevalence and correlates of arterial vascular events in Hispanics from Puerto Rico with RA. Patients with extra-articular manifestations and greater disability as well as those with traditional risk factors for cardiovascular disease were at higher risk. Awareness of these factors may lead to more effective management strategies of patients at risk for arterial vascular events.


Disclosure: A. González-Meléndez, None; R. Fred-Jimenez, None; M. Arroyo-Ávila, None; L. Díaz-Correa, None; N. Pérez-Ríos, None; N. Rodríguez-Pérez, None; G. Ríos, None; L. M. Vilá, None.

To cite this abstract in AMA style:

González-Meléndez A, Fred-Jimenez R, Arroyo-Ávila M, Díaz-Correa L, Pérez-Ríos N, Rodríguez-Pérez N, Ríos G, Vilá LM. Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/arterial-vascular-events-in-hispanics-from-puerto-rico-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/arterial-vascular-events-in-hispanics-from-puerto-rico-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology